Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 26596

AbstractMaterial and MethodsResultsDiscussionConclusionKey MessageAcknowledgementReferences
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"

Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018

Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."

Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018

Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."

Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018

Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."

Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
On Sep 2018

Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."

Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata

Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
On Aug 2018

Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".

Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
On Aug 2018

Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".

Dr. Mamta Gupta
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018

Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.

Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."

Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
On May 11,2011

Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."

Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
On April 2011

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.

Dr. Anuradha
On Jan 2020

Important Notice

Original article / research
Year : 2007 | Month : October | Volume : 1 | Issue : 5 | Page : 377 - 379

Subtenons vs. Intravitreal Triamcinolone in Refractory Diabetic Macular Oedema


Ophthalmology Department, Hull and East Yorkshire Eye Hospitals, Hull HU3 2JZ, UK

Correspondence Address :
Indira Moorthy Madgula. 2A Fellsdyke Court, Gateshead, NE10 9SB.Tel.: 0044 07832212783; fax: 0044 01482 605327; e-mail:


Diabetic macular oedema has been treated with triamcinolone acetonide (TA) with varying results. The study aimed to compare the effectiveness of intravitreal vs. posterior subtenons injection of TA for treatment of refractory diabetic macular oedema.
Method: Twelve patients received 40 mg of subtenons triamcinolone (STA) and 15 received 4 mg of intravitreal triamcinolone (IVTA).
Results: IVTA and STA groups demonstrated a reduction in macular thickness of 48.4% and 12.4%, respectively, at 1 month. IVTA eyes remained statistically thinner at 3 months but not at 6 months. In the IVTA group, 50% had an improved visual acuity and 35.7% a stable visual acuity. Vision improved in 33.3% of patients in STA group and remained stable in 50%. Change in visual acuity was not statistically significant between the two groups.
Conclusion: This study does not advocate the superiority of one route of administration of TA over another and recommends randomised control trials to establish best practise in this field.
Key messages: Intravitreal and subtenons triamcinolone are equally effective in transiently improving vision in refractory diabetic macular oedema.


Macular oedema, triamcinolone acetonide, subtenons, intravitreal

Diabetic retinopathy is one of the leading causes of blindness in the developed world (1). Macular oedema affects approximately 29% of diabetics with disease duration of 20 years or more. It is the main reason for reduced vision in these patients (2). Triamcinolone acetonide (TA) is a glucocorticosteroid suspension with antiangiogenic and antioedema properties. Administered as a periocular injection or intravitreally, it has been used to treat macular oedema of varying aetiology (1). TA has also been reported to have favourable results in treatment of diffuse diabetic macular oedema (1),(2),(3).

Aim: To compare the effectiveness of intravitreal vs. posterior subtenons injection of TA for treatment of refractory diabetic macular oedema.

Material and Methods

A total of 27 patients with refractory diffuse diabetic macular oedema were enrolled. Diffuse macular oedema was defined by central thickening on bio-microscopy using a 78-D noncontact lens and by diffuse fluorescein leakage, involving most of the macular area on fluorescein angiography. All focal leaks had previously been treated by laser photocoagulation. Baseline data included duration of macular oedema, number of laser sessions, subjective refraction, best-corrected visual acuity, Goldman applanation tonometry, fluorescein angiography, and macular thickness mapping using optical coherence tomogram (OCT). Patients received either 40 mg of subtenons triamcinolone (STA) or 4 mg of intravitreal triamcinolone (IVTA). Patients were seen before injection and 1 week, 1 month, 3 months, and 6 months after the injection. Primary outcomes were monitored anatomically by OCT macular thickness and functionally by visual acuity assessments at 1-, 3-, and 6-month post-injection visits. Secondary outcomes, which were potential corticosteroid- and injection-related complications, were also observed. Data were analysed using an SPSS package.


A total of 27 patients (20 males, seven females) with a mean age of 65.03 ± 8.95 years (age range 44–84 years) were recruited into either the intravitreal triamcinolone acetonide group (IVTA) or the subtenons triamcinolone acetonide group (STA) for the study. Age was normally distributed (Kolmogorov–Smirnov test) in both research groups, and there was no significant difference in gender, duration of diabetes, and past laser treatments between the two groups. The mean duration of diabetes was 15.4 years. The average duration of macular oedema pre-intervention was 13.07 months in either group. The mean number of laser treatments was 3.1. All eyes were phakic and had macular oedema refractory to laser therapy. Twelve patients underwent a subtenons TCA (40 mg) injection, while 15 had an intravitreal TCA (4 mg) injection.

Anatomical outcome
One month after injection, IVTA- and STA-injected eyes demonstrated a reduction in mean macular thickness of 48.4% and 12.4%, respectively. The central macular thickness in IVTA-injected eye remained statistically thinner than in the STA eyes at 3 months. At 6 months, this difference was no longer significant.

Functional outcome
At the pre-intervention time point, there was no significant difference between the visual acuity in the two research groups. Visual acuity improved in 33.3% of patients in STA group, remained stable in 50% of patients, and worsened in the remaining 16.7% patients at 3-month follow-up. In the IVTA group, 50% of patients had an improved visual acuity, whereas the vision remained stable in 35.7% of patients. However, the vision worsened in 14.3% of patients at 3-month follow-up. Statistically, there was no significant difference between the two research groups and average change in visions (p = 0.165).

Neither the IVTA group nor the STA group had statistically significant changes in the IOP (p = 0.127). Serious complications that could be related to the TA injection (such as vitreous haemorrhage, endophthalmitis, retinal detachment, and inadvertent ocular perforation) were not observed.


Machemer et al. first advocated the use of intravitreal corticosteroid for the treatment of proliferative vitreoretinopathy(4). The rationale behind their use lies in their ability to inhibit the arachodonic acid pathway, of which prostaglandin is a product. TCA has been shown to reduce the breakdown of the blood–retinal barrier (3),(5). TCA has been used for the treatment of macular oedema of varying aetiology, especially diffuse macular oedema refractory to grid laser photocoagulation, with promising short-term results (3),[6–10]. The short-term efficacy has been attributed to a mean elimination half-life of 18.6 days for TCA, which lasts in the vitreous for only 3 months (7). The present study allows comparison of IVTA with STA injection for refractory diabetic macular oedema regarding safety, anatomic, and functional outcomes. Quantitative measurements of retinal thickness by OCT showed a reduction from baseline at 1- and 3-month follow-up visits that were not sustained at 6 months. The improvement in visual acuity was not statistically significant between the two groups, though the injections were well tolerated by all patients without any reports of sight-threatening complications. Long-standing macular oedema as was recorded in the study groups may have been responsible for disruptive changes in the retina and irreversible damage to the photoreceptors, leading to a decreased efficacy of IVTA over STA in improving the anatomical and visual outcome. This is in contrast to other studies that have reported a clear short-term advantage of the intravitreal injection over the subtenons route in a small series of patients (2),(11),(12).

The drawbacks of our study were a small sample size and a short duration of follow-up. A bigger patient group (n = 69) would be required to calculate a statistically significant difference between the IVTA and STA groups.


Both IVTA and STA injections may be equally tolerated in patients with refractory diffuse diabetic macular oedema, with a short-term improvement in functional and anatomical outcome in both groups. This study does not advocate the use of TA injection by one route over the other for the treatment of diabetic macular oedema. Randomised controlled trials need to be done in a larger group of patients with long-term follow-up to decide the superiority of intravitreal vs. subtenons steroid or the efficacy of repeated injections of TCA in the long term.

Key Message

Intravitreal and subtenons triamcinolone are equally effective in transiently improving vision in refractory diabetic macular oedema.


I am thankful to all the participants in the study and to Rachel Waddington for all her help in statistical analysis of the data.


Ulla F, Marticorena J, Alfaro DV, III, et al. Intravitreal triamcinolone for the treatment of diabetic macular edema. Curr Diabetes Rev 2006;2(1):99–112.
Cardillo AJ, Luiz AS, Rogerio AC. Comparison of intravitreal versus posterior sub-tenons capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology 2005;112:1557–63.
Kosobucki BR, Freeman WR, Cheng L. Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye. Br J Ophthalmol 2006;90:705–8.
Machemer R, Sugita G. Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 1979;77:171-180.
Ciardella AP, Klancnik J, Schiff W. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 2004;88:1131–6.
Er H, Yilmaz H. Intravitreal cortisone injection for refractory diffuse diabetic macular oedema. Ophthalmologica 2005;219(6):394–400.
Longo A. Intravitreal triamcinolone for diffuse diabetic macular oedema. Br J Ophthalmol 2006;90:1079–80.
Jonas JB, Akkoyun I, Kreissig I, et al. Diffuse diabetic macular edema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study. Br J Ophthalmol 2005;89(3):321–6.
Sorensen TL, Haamann P, Villumsen J, et al. Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology. Acta Ophthalmol Scand 2005;83(1):67–70.
Ozkiris A, Evereklioglu C, Erkilic K, et al. Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema. Eur J Ophthalmol 2004;14(6):543–9.
Bonini-Filho MA, Jorge R, Barbosa JC, et al. Intravitreal injection versus subtenons infusion of triamcinolone acetonide for refractory diabetic macular oedema: a randomised control trial. Invest Ophthalmol Vis Sci 2005;46(10):3845–9.
Ozdek S, Bahceci UA, Gurelik G, et al. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular oedema. J Diabetes

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)